{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:33:46Z","timestamp":1788395626086,"version":"build-2803163510"},"reference-count":47,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although intravenous (IV) direct thrombin inhibitors (DTI) have gained interest in pediatric extracorporeal membrane oxygenation (ECMO), dosing and safety information is limited. The objective of this systematic review was to characterize DTI types, dosing, monitoring, and outcomes (bleeding and thromboembolic) in pediatric ECMO patients managed with IV DTIs. We conducted searches of MEDLINE (Ovid) and Embase (Elsevier) from inception through December 2022. Case reports, retrospective studies, and prospective studies providing per-patients or summary data for patient(s) &lt;18 years of age receiving IV DTI for ECMO anticoagulation were included. Study selection and data extraction were conducted independently by two reviewers. A total of 28 studies: 14 case reports, 13 retrospective studies, and 1 prospective study were included, totaling 329 patients. Bivalirudin was utilized in 318 (96.7%), argatroban in 9 (2.7%), and lepirudin in 2 (0.6%) patients. Infusion dosing included: bivalirudin 0.14\u2009\u00b1\u20090.37\u2009mg\/kg\/h, argatroban 0.69\u2009\u00b1\u20090.73 \u00b5g\/kg\/min, lepirudin 0.14\u2009\u00b1\u20090.02\u2009mg\/kg\/h. Laboratory monitoring tests utilized were the activated clotting time, activated partial thromboplastin time (aPTT), diluted thrombin time, and thromboelastography measures. The aPTT was utilized in most patients (95%). Thromboembolism, bleeding, or death were observed in 17%, 17%, and 23% of bivalirudin, argatroban, and lepirudin patients, respectively. Bivalirudin appears to be the most frequently used DTI in pediatric ECMO. Dosing and laboratory monitoring varied, and bleeding and thromboembolic events were reported in 17% of patients. Prospective studies are warranted to establish dosing, monitoring, safety, and efficacy of bivalirudin and other IV DTI in pediatric ECMO.<\/jats:p>","DOI":"10.1055\/s-0043-1772838","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:36:07Z","timestamp":1693337767000},"page":"756-763","source":"Crossref","is-referenced-by-count":16,"title":["Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature"],"prefix":"10.1055","volume":"49","author":[{"given":"Amy L.","family":"Kiskaddon","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Johns Hopkins All Children's Hospital, St. Petersburg, Florida"},{"name":"Department of Pediatrics, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhue L.","family":"Do","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiac Surgery, Section of Surgical Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee"},{"name":"Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Williams","sequence":"additional","affiliation":[{"name":"Medical Library, Johns Hopkins All Children's Hospital, St. Petersburg, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Betensky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology, Johns Hopkins School of Medicine, Baltimore, Maryland"},{"name":"Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology, Johns Hopkins School of Medicine, Baltimore, Maryland"},{"name":"Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida"},{"name":"Departments of Pediatrics and Medicine, Division of Hematology, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"09","key":"ref1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/jpc.16151","article-title":"Extracorporeal membrane oxygenation in children: A brief review","volume":"58","author":"K Sakurai","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"ref2","first-page":"25","volume-title":"The ECMO Circuit","author":"A Vuylsteke","year":"2017"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tmrv.2014.12.001","article-title":"Extracorporeal membrane oxygenation-hemostatic complications","volume":"29","author":"D A Murphy","year":"2015","journal-title":"Transfus Med Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2018.05.009","article-title":"Anticoagulation during ECMO in neonatal and paediatric patients","volume":"173","author":"R Barton","year":"2019","journal-title":"Thromb Res"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"M Andrew","year":"1987","journal-title":"Blood"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1160\/TH09-09-0624","article-title":"Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin","volume":"103","author":"F Newall","year":"2010","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.thromres.2005.11.004","article-title":"Age-related differences in heparin response","volume":"118","author":"V Ignjatovic","year":"2006","journal-title":"Thromb Res"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/PCC.0000000000002696","article-title":"Anticoagulation and transfusion management during neonatal and pediatric extracorporeal membrane oxygenation: a survey of medical directors in the United States","volume":"22","author":"C P Ozment","year":"2021","journal-title":"Pediatr Crit Care Med"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-021-02546-9","article-title":"Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: epidemiology, outcomes, and diagnostic challenges","volume":"53","author":"A M Zaaqoq","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"03","key":"ref10","first-page":"481","article-title":"Lepirudin in the management of patients with heparin-induced thrombocytopenia","volume":"2","author":"S Petros","year":"2008","journal-title":"Biologics"},{"issue":"02","key":"ref11","first-page":"105","article-title":"The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT","volume":"1","author":"A Koster","year":"2007","journal-title":"Biologics"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.beha.2004.02.002","article-title":"Bivalent direct thrombin inhibitors: hirudin and bivalirudin","volume":"17","author":"T E Warkentin","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1592\/phco.26.5.709","article-title":"Lepirudin anticoagulation for heparin-induced thrombocytopenia after cardiac surgery in a pediatric patient","volume":"26","author":"C A Knoderer","year":"2006","journal-title":"Pharmacotherapy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fmed.2018.00361","article-title":"Coagulation and bleeding management in pediatric extracorporeal membrane oxygenation: clinical scenarios and review","volume":"5","author":"L A Hensch","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1051\/ject\/201850030","article-title":"Anticoagulation management during first five days of infant-pediatric extracorporeal life support","volume":"50","author":"K R Bingham","year":"2018","journal-title":"J Extra Corpor Technol"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1067\/mpd.2002.121384","article-title":"Lepirudin anticoagulation for heparin-induced thrombocytopenia","volume":"140","author":"S R Deitcher","year":"2002","journal-title":"J Pediatr"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1345\/aph.1D436","article-title":"Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation","volume":"38","author":"W E Dager","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.healun.2006.08.005","article-title":"Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia","volume":"25","author":"C S Almond","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.PCC.0000200966.56379.95","article-title":"Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban","volume":"7","author":"L K Scott","year":"2006","journal-title":"Pediatr Crit Care Med"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1213\/ANE.0b013e3181f334a6","article-title":"Case report: pediatric liver retransplantation on an extracorporeal membrane oxygenation-dependent child","volume":"111","author":"I S Landsman","year":"2010","journal-title":"Anesth Analg"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1089253215624766","article-title":"Challenging argatroban management of a child on extracorporeal support and subsequent heart transplant","volume":"20","author":"G J Latham","year":"2016","journal-title":"Semin Cardiothorac Vasc Anesth"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jtcvs.2018.02.001","article-title":"Heart transplant after profoundly extended ambulatory central venoarterial extracorporeal membrane oxygenation","volume":"156","author":"Y Shudo","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejccm.2018.12.015","article-title":"One hundred forty six days on extracorporeal membrane oxygenation (ECMO): our longest ECMO run","volume":"6","author":"A Ali","year":"2018","journal-title":"The Egyptian Journal of Critical Care Medicine."},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/ject\/201143005","article-title":"Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature","volume":"43","author":"U Pollak","year":"2011","journal-title":"J Extra Corpor Technol"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2150135114553476","article-title":"Plasma exchange on venovenous extracorporeal membrane oxygenation with bivalirudin anticoagulation","volume":"6","author":"T J Preston","year":"2015","journal-title":"World J Pediatr Congenit Heart Surg"},{"issue":"08","key":"ref26","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/ajt.13239","article-title":"Successful semi-ambulatory veno-arterial extracorporeal membrane oxygenation bridge to heart-lung transplantation in a very small child","volume":"15","author":"J Y Wong","year":"2015","journal-title":"Am J Transplant"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/chd.12557","article-title":"Heparin-induced thrombocytopenia complicating children after the Fontan procedure: single-center experience and review of the literature","volume":"13","author":"U Pollak","year":"2018","journal-title":"Congenit Heart Dis"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejccm.2018.12.009","article-title":"A case of HITT in a child on extracorporeal membrane oxygentation","volume":"6","author":"K Kunchapudi","year":"2018","journal-title":"Egyptian J Crit Care Med."},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/ject\/201951026","article-title":"Bivalirudin anticoagulation for an infant with hyperbilirubinemia and elevated plasma-free hemoglobin on ECMO","volume":"51","author":"C Ezetendu","year":"2019","journal-title":"J Extra Corpor Technol"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPH.0b013e3180463626","article-title":"Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support","volume":"29","author":"K E Potter","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1186\/cc10556","article-title":"Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation","volume":"15","author":"M Ranucci","year":"2011","journal-title":"Crit Care"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/PCC.0b013e31827200b6","article-title":"Bivalirudin in pediatric patients maintained on extracorporeal life support","volume":"14","author":"E L Nagle","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s13054-014-0504-2","article-title":"Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients","volume":"18","author":"M Ranucci","year":"2014","journal-title":"Crit Care"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.12.007","article-title":"Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: thromboelastometry versus routine coagulation testing","volume":"186","author":"J Teruya","year":"2020","journal-title":"Thromb Res"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/aor.13758","article-title":"Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center","volume":"45","author":"M R Schill","year":"2021","journal-title":"Artif Organs"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.thromres.2020.07.043","article-title":"A perioperative bivalirudin anticoagulation protocol for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation","volume":"193","author":"C W Snyder","year":"2020","journal-title":"Thromb Res"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1060028020937819","article-title":"Description of bivalirudin use for anticoagulation in pediatric patients on mechanical circulatory support","volume":"55","author":"C T Campbell","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/MAT.0000000000001818","article-title":"Evaluation of bivalirudin dosing in pediatric extracorporeal membrane oxygenation with renal insufficiency or renal replacement therapy","volume":"68","author":"M Hamzah","year":"2022","journal-title":"ASAIO J"},{"issue":"09","key":"ref39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/PCC.0000000000002384","article-title":"Evaluation of bivalirudin as an alternative to heparin for systemic anticoagulation in pediatric extracorporeal membrane oxygenation","volume":"21","author":"M Hamzah","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/02676591211034314","article-title":"Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO)","volume":"38","author":"S Kaushik","year":"2023","journal-title":"Perfusion"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/MAT.0000000000001681","article-title":"Impact of continuous renal replacement therapy on bivalirudin dosing in pediatric extracorporeal membrane oxygenation","volume":"68","author":"M A Lahart","year":"2022","journal-title":"ASAIO J"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MAT.0000000000001291","article-title":"Bivalirudin may reduce the need for red blood cell transfusion in pediatric cardiac patients on extracorporeal membrane oxygenation","volume":"67","author":"D S Machado","year":"2021","journal-title":"ASAIO J"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/PCC.0000000000002527","article-title":"Prospective exploratory experience with bivalirudin anticoagulation in pediatric extracorporeal membrane oxygenation","volume":"21","author":"L M Ryerson","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"09","key":"ref44","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/j.1538-7836.2011.04433.x","article-title":"Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children","volume":"9","author":"L G Mitchell","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO adult and pediatric anticoagulation guidelines","volume":"68","author":"A BV McMichael","year":"2022","journal-title":"ASAIO J"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"106089","DOI":"10.1016\/j.phrs.2022.106089","article-title":"Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: a systematic review and meta-analysis","volume":"177","author":"L Liu","year":"2022","journal-title":"Pharmacol Res"},{"issue":"09","key":"ref48","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","article-title":"Comparison of bivalirudin versus heparin for maintenance systemic anticoagulation during adult and pediatric extracorporeal membrane oxygenation","volume":"49","author":"T G Seelhammer","year":"2021","journal-title":"Crit Care Med"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1772838.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:20:02Z","timestamp":1695324002000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1772838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":47,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2023,9,21]]},"published-print":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1772838","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]}}}